Remacemide is a low-affinity NMDA receptor antagonist that also exhibits sodium channel blocking activity. It has been investigated in preclinical and clinical research for neurological conditions including epilepsy, Parkinsons disease, Huntingtons disease, and acute ischemic stroke.
Molecular Weight:
268.35
CAS Number:
[128298-28-2]
Formula:
C17H20N2O
Target:
Others,iGluR
* VAT and and shipping costs not included. Errors and price changes excepted